Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Icure Pharm Inc (175250 KS)
Watchlist
22
Analysis
Health Care
•
South Korea
Icure Pharm. Inc. manufactures and distributes biopharmaceuticals. The Company produces drugs, cosmetics, and other biopharmaceuticals. Icure Pharm markets its products worldwide.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Coocon Corp
•
05 Oct 2021 07:34
KOSDAQ150 Index Rebalance Preview: Here Comes the Pullback
With 85% of the review period complete, we see 16 changes for the KQ150 Index at the Dec rebal. The potential adds have outperformed the deletes...
Brian Freitas
Follow
667 Views
Share
bullish
•
Wonik QnC Corp
•
05 Aug 2021 07:44
KOSDAQ150 Index Rebalance Preview: Inclusions Outperforming as Short Sell Ban Helps
Halfway through the review period, we see 15 potential changes to the index. The potential inclusions are outperforming the exclusions as short...
Brian Freitas
Follow
513 Views
Share
bullish
•
Wonik QnC Corp
•
07 Jun 2021 13:33
KOSDAQ150 Index Rebalance Preview: Lots of Changes Early in the Review Period
A month into the review period for the KOSDAQ150 December rebalance, we can already see 12 potential changes. The potential inclusions should...
Brian Freitas
Follow
449 Views
Share
bullish
•
Hana Materials Inc
•
25 May 2021 18:41
KOSDAQ150 Index Rebalance: 16 Changes & Large Turnover
There are 16 changes to the KOSDAQ150 index resulting in a one-way turnover of 7.04%. The impact on the exclusions is a lot higher than on the...
Brian Freitas
Follow
619 Views
Share
bullish
•
SK Oceanplant
•
25 May 2021 18:31
KOSDAQ 150 Rebalancing Results: Changes, Passive Flow, & Trade Approach
The KRX has just announced the results of the KOSPI 200 semi-annual rebalancing. This post examines the passive flow of the adds and deletes as...
Sanghyun Park
Follow
509 Views
Share
Previous
1
2
3
4
5
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x